John Spellman is an Executive Therapeutic Specialist at Gilead Sciences, where they focus on Hepatitis B and have received several accolades for their leadership and sales achievements, including the 2019 Letairis Market Leadership Award. With over 25 years of experience in pharmaceutical sales, they have a proven track record in various disease states and have successfully launched multiple products, such as Glucovance and Plavix, during their tenure at Bristol-Myers Squibb and Scios Inc. Additionally, John has excelled in training and developing sales representatives, demonstrating a commitment to teamwork and professional growth. They hold a Bachelor of Arts in Psychology from Rutgers University.
Location
Scotch Plains, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices